Type 2 diabetes is one of Malaysia’s most common chronic conditions, and also one of the most researched areas in regenerative medicine. This page explains how type 2 diabetes is diagnosed, what standard endocrinology-led care looks like, and what current stem cell research can and cannot show, so you can have an informed conversation before requesting an assessment.
Symptoms and Diagnosis
Type 2 diabetes often develops gradually, and many people in Malaysia are diagnosed through routine screening before symptoms become obvious.
| Presentation | Common Signs |
| Early/undiagnosed | Often asymptomatic; detected via routine blood sugar screening |
| Developing symptoms | Increased thirst, frequent urination, fatigue, blurred vision |
| Longer-term, poorly controlled | Slow-healing wounds, recurrent infections, numbness or tingling in extremities |
Diagnosis typically involves:
- Fasting blood glucose testing
- HbA1c, reflecting average blood sugar control over the preceding 2 to 3 months
- Oral glucose tolerance test (OGTT), used in certain diagnostic situations
- Screening for complications, including kidney function, eye examination, and foot assessment, particularly for those with longer-standing diabetes
Standard Care for Type 2 Diabetes
Endocrinology and primary care-led management remains the evidence-based foundation of type 2 diabetes treatment, focused on blood sugar control and preventing long-term complications.
| Approach | Purpose |
| Lifestyle modification | Diet, weight management, and physical activity as first-line management |
| Oral medications (metformin and others) | Improving insulin sensitivity or glucose regulation |
| Newer medication classes (SGLT2 inhibitors, GLP-1 agonists) | Blood sugar control with additional cardiovascular and kidney benefits in eligible patients |
| Insulin therapy | For patients whose blood sugar isn’t adequately controlled with oral medications alone |
| Regular monitoring | HbA1c checks, kidney function, eye, and foot screening to catch complications early |
| Managing associated conditions | Blood pressure and cholesterol management, given diabetes’ strong link to cardiovascular risk |
This standard pathway remains the foundation of diabetes management, and any discussion of stem cell therapy should be understood as sitting alongside, not replacing, ongoing endocrinology-led care.
What Current Research Can and Cannot Show
Stem cell research in type 2 diabetes is a genuinely active field, exploring effects on insulin resistance, pancreatic function, and diabetes-related complications.
What current research suggests:
- Some early and mid-phase studies have explored MSC administration’s potential effects on insulin sensitivity and inflammatory markers associated with type 2 diabetes
- Researchers have also studied regenerative approaches for diabetes-related complications, such as diabetic wounds and, separately, diabetic kidney disease
- Proposed mechanisms generally centre on immune modulation and paracrine signalling rather than direct replacement of insulin-producing cells, which remains a much earlier-stage research area, particularly for type 1 diabetes
What current evidence does not establish:
- No regulatory authority has approved stem cell therapy as a treatment that reverses or cures type 2 diabetes
- Stem cell therapy is not established as a way to eliminate the need for diabetes medication or insulin
- Results across published studies remain inconsistent, with variation in cell source, dose, and study design
- Long-term data on durability of any observed benefit remains limited
At 23C Regen, any discussion of type 2 diabetes is grounded in this evidence picture. We do not claim to reverse diabetes or replace the need for medication or insulin. An assessment is about reviewing your specific situation honestly against what current evidence actually supports.
Risks and Exclusions
General risks associated with MSC administration can include:
- Infusion-related reactions
- Rare allergic or immune responses
- The need for careful coordination with your existing diabetes medications and monitoring routine
Patients who may be excluded from assessment or treatment can include those with:
- Poorly controlled blood sugar requiring urgent medical stabilisation first
- Active, untreated infection
- Active malignancy, pending oncology clearance
- Significant uncontrolled diabetes-related complications requiring immediate specialist management
- Pregnancy
Assessment Records You’ll Need
- Recent HbA1c and fasting glucose results
- A list of current diabetes medications, including insulin regimen if applicable
- Recent complication screening results (kidney function, eye exam, foot assessment)
- Endocrinologist’s notes, if you’re already under specialist care
- Relevant cardiovascular history, given diabetes’ close link to heart and kidney health.
Follow-Up
Type 2 diabetes requires lifelong management regardless of treatment path chosen. Our approach includes:
- A clear explanation of findings after your initial assessment
- Honest guidance on whether stem cell therapy is a reasonable option to discuss further
- Coordination notes you can share with your treating endocrinologist or GP
- Scheduled review points if you proceed with treatment, alongside continued standard diabetes monitoring
Questions to Discuss During Your Assessment
- What does current evidence actually show for someone with my specific diabetes history and complications?
- Will this replace or reduce my need for diabetes medication or insulin?
- How does this coordinate with my existing endocrinology care?
- What are the risks given my overall health and current medications?
- How will my blood sugar control be monitored during and after any treatment?
Diabetes-Related Complications Worth Understanding
Type 2 diabetes rarely stays isolated to blood sugar alone, and understanding how it connects to other organ systems matters when thinking about your overall health picture.
| Complication Area | Why Regular Monitoring Matters |
| Kidney function | Diabetic kidney disease is a leading cause of CKD in Malaysia; see our chronic kidney disease page |
| Eye health | Diabetic retinopathy can develop without symptoms; regular eye screening is essential |
| Nerve health | Peripheral neuropathy can affect sensation, particularly in the feet |
| Cardiovascular health | Diabetes significantly raises cardiovascular risk, making blood pressure and cholesterol control equally important |
| Foot health | Reduced sensation combined with poor circulation raises risk of slow-healing wounds |
Any assessment for stem cell therapy should be considered within this broader context, not as an isolated decision separate from your overall diabetes management and complication screening schedule.
Why a Documented Assessment Matters More Than a General Opinion
Diabetes management decisions carry real weight, given how closely blood sugar control is tied to long-term complication risk. A general conversation about symptoms, without reviewing your actual HbA1c trend, current medication regimen, and complication screening results, cannot responsibly determine whether any additional treatment is appropriate to discuss. This is why we ask for documented records before any specific recommendation.
Frequently Asked Questions
Can stem cell therapy cure type 2 diabetes?
No. There is currently no cure for type 2 diabetes, and stem cell therapy is not established as reversing the underlying condition.
Will this treatment let me stop taking my diabetes medication?
We cannot guarantee that. Medication decisions are based on your blood sugar control and overall health, determined by your treating doctor.
Is this suitable if my diabetes is currently poorly controlled?
Not immediately. Blood sugar typically needs to be reasonably stabilised first before considering any additional treatment, for safety reasons.
Does this treatment help with diabetic kidney disease too?
Diabetic kidney disease is a related but distinct concern. Our chronic kidney disease page covers this specific area separately.
What type of stem cells does 23C Regen use for diabetes?
We use laboratory-cultured Wharton’s Jelly-derived mesenchymal stem cells. Your doctor will explain the specific protocol considered for your case during assessment.
Do I need an endocrinologist’s referral to book an assessment?
A referral isn’t required, but bringing recent HbA1c results and your endocrinologist’s notes helps us provide a more accurate, informed assessment.
Request a Diabetes Health Assessment
If you’d like an honest, evidence-based conversation about your type 2 diabetes and what current research can and cannot offer, request an assessment. Review our full list of treatable conditions.